PRTC
Price
$18.02
Change
+$0.01 (+0.06%)
Updated
Jul 8, 01:45 PM (EDT)
Capitalization
417.8M
50 days until earnings call
RLMD
Price
$0.61
Change
-$0.00 (-0.00%)
Updated
Jul 8, 04:59 PM (EDT)
Capitalization
20.25M
35 days until earnings call
Interact to see
Advertisement

PRTC vs RLMD

Header iconPRTC vs RLMD Comparison
Open Charts PRTC vs RLMDBanner chart's image
PureTech Health
Price$18.02
Change+$0.01 (+0.06%)
Volume$100
Capitalization417.8M
Relmada Therapeutics
Price$0.61
Change-$0.00 (-0.00%)
Volume$1.9K
Capitalization20.25M
PRTC vs RLMD Comparison Chart in %
Loading...
PRTC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RLMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PRTC vs. RLMD commentary
Jul 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PRTC is a Buy and RLMD is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 09, 2025
Stock price -- (PRTC: $18.08 vs. RLMD: $0.61)
Brand notoriety: PRTC and RLMD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PRTC: 42% vs. RLMD: 27%
Market capitalization -- PRTC: $417.8M vs. RLMD: $20.25M
PRTC [@Biotechnology] is valued at $417.8M. RLMD’s [@Biotechnology] market capitalization is $20.25M. The market cap for tickers in the [@Biotechnology] industry ranges from $309.49B to $0. The average market capitalization across the [@Biotechnology] industry is $2.39B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PRTC’s FA Score shows that 0 FA rating(s) are green whileRLMD’s FA Score has 1 green FA rating(s).

  • PRTC’s FA Score: 0 green, 5 red.
  • RLMD’s FA Score: 1 green, 4 red.
According to our system of comparison, RLMD is a better buy in the long-term than PRTC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PRTC’s TA Score shows that 5 TA indicator(s) are bullish while RLMD’s TA Score has 5 bullish TA indicator(s).

  • PRTC’s TA Score: 5 bullish, 2 bearish.
  • RLMD’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, PRTC is a better buy in the short-term than RLMD.

Price Growth

PRTC (@Biotechnology) experienced а +4.81% price change this week, while RLMD (@Biotechnology) price change was -0.97% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.39%. For the same industry, the average monthly price growth was +14.41%, and the average quarterly price growth was +12.94%.

Reported Earning Dates

PRTC is expected to report earnings on Aug 27, 2025.

RLMD is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+9.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRTC($418M) has a higher market cap than RLMD($20.3M). RLMD YTD gains are higher at: 17.346 vs. PRTC (-2.438). PRTC has higher annual earnings (EBITDA): -53.65M vs. RLMD (-79.12M). PRTC has more cash in the bank: 502M vs. RLMD (27.1M). RLMD has less debt than PRTC: RLMD (256K) vs PRTC (24M). PRTC (0) and RLMD (0) have equivalent revenues.
PRTCRLMDPRTC / RLMD
Capitalization418M20.3M2,059%
EBITDA-53.65M-79.12M68%
Gain YTD-2.43817.346-14%
P/E Ratio8.61N/A-
Revenue00-
Total Cash502M27.1M1,852%
Total Debt24M256K9,375%
FUNDAMENTALS RATINGS
RLMD: Fundamental Ratings
RLMD
OUTLOOK RATING
1..100
62
VALUATION
overvalued / fair valued / undervalued
1..100
20
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PRTCRLMD
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
85%
MACD
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
82%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
Bearish Trend 14 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
82%
Aroon
ODDS (%)
Bullish Trend 2 days ago
64%
Bullish Trend 2 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
PRTC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RLMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RUSMF32.390.10
+0.32%
Russel Metals Inc.
TLSNY7.200.01
+0.14%
Telia Company AB
FIQAX16.74N/A
N/A
Fidelity Advisor Asset Manager 60% Z
QUTIF0.20N/A
N/A
Questor Technology, Inc.
SOCLF0.27N/A
N/A
Pharos Energy PLC

PRTC and

Correlation & Price change

A.I.dvisor tells us that PRTC and ZLAB have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PRTC and ZLAB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRTC
1D Price
Change %
PRTC100%
N/A
ZLAB - PRTC
32%
Poorly correlated
-2.53%
RLMD - PRTC
31%
Poorly correlated
-3.14%
AUTL - PRTC
30%
Poorly correlated
-4.64%
IRON - PRTC
30%
Poorly correlated
-2.50%
PTCHF - PRTC
29%
Poorly correlated
N/A
More

RLMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, RLMD has been loosely correlated with SYRE. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if RLMD jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLMD
1D Price
Change %
RLMD100%
-3.14%
SYRE - RLMD
36%
Loosely correlated
-2.92%
ENTO - RLMD
36%
Loosely correlated
-1.44%
PRTC - RLMD
31%
Poorly correlated
N/A
AVXL - RLMD
31%
Poorly correlated
-7.41%
ZVRA - RLMD
29%
Poorly correlated
+19.77%
More